2 months ago
ASML
AnalystsDavid DaiDavid Dai's Stock Forecasts
AnalystsDavid Dai
Analyst Ranking
Bottom 16%
#4400 out of 5216 analysts
Average Return
-0.61%
Win Rate
38%12 out of 32
Risk vs Reward
Poor
Good
David Dai's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Syndax Pharmaceuticals IncSNDX | +160.48% | $9.21 | $23.99 | 2025-07-15 - 2026-03-12 | Strong Buy |
Perspective Therapeutics IncCATX | +144.50% | $2.09 | $5.11 | 2025-11-21 - 2026-03-12 | Strong Buy |
Jdcom IncJD | +122.61% | $38.35 | $85.37 | 2020-03-17 - 2021-03-17 | Buy |
Merus NvMRUS | +80.02% | $52.30 | $94.15 | 2024-10-24 - 2025-09-30 | Strong Buy |
Cullinan Therapeutics IncCGEM | +76.36% | $7.91 | $13.95 | 2025-05-12 - 2026-03-12 | Strong Buy |
David Dai Analyst Color
Get additional color on David Dai's coverage of popular stocks
David Dai's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Iovance Biotherapeutics IncIOVA | 3 | Hold | $4.00 | -1.72% | Maintains | 8 days ago |
Kymera Therapeutics IncKYMR | 1 | Strong Buy | $128.00 | +65.16% | Maintains | 10 days ago |
Asml Holding NvASML | 2 | Buy | $1,642.00 | +21.49% | Maintains | 2 months ago |
Sony Group CorpSONY | 1 | Buy | $30.00 | +39.79% | Maintains | 2 months ago |
Perspective Therapeutics IncCATX | 2 | Strong Buy | $7.00 | +36.99% | Maintains | 4 months ago |
Kura Oncology IncKURA | 3 | Strong Buy | $16.00 | +81.00% | Maintains | 4 months ago |
Biontech SeBNTX | 1 | Hold | $117.00 | +29.86% | Maintains | 4 months ago |
Syndax Pharmaceuticals IncSNDX | 3 | Strong Buy | $38.00 | +58.40% | Maintains | 4 months ago |
Nuvalent IncNUVL | 3 | Strong Buy | $132.00 | +34.69% | Maintains | 4 months ago |
Merus NvMRUS | 2 | Hold | $97.00 | +7.78% | Downgrades | 5 months ago |
Telix Pharmaceuticals LtdTLX | 1 | Strong Buy | $20.00 | +153.49% | Maintains | 6 months ago |
Nurix Therapeutics IncNRIX | 2 | Strong Buy | $26.00 | +66.56% | Maintains | 8 months ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $30.00 | +94.05% | Initiates Coverage On | 8 months ago |
Blueprint Medicines CorpBPMC | 2 | Hold | $129.00 | -0.36% | Maintains | 9 months ago |
Cullinan Therapeutics IncCGEM | 2 | Strong Buy | $24.00 | +72.04% | Maintains | 10 months ago |
Immunocore Holdings PLCIMCR | 1 | Strong Sell | $24.00 | N/A | Initiates Coverage On | a year ago |
Janux Therapeutics IncJANX | 1 | Strong Buy | $69.00 | N/A | Initiates Coverage On | a year ago |
Ideaya Biosciences IncIDYA | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | a year ago |
Cg Oncology IncCGON | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | a year ago |
Adicet Bio IncACET | 1 | Buy | $448.00 | N/A | Initiates Coverage On | 4 years ago |
Jounce Therapeutics IncJNCE | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 4 years ago |
Inhibrx IncINBX1 | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Macrogenics IncMGNX | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 4 years ago |
Nkarta IncNKTX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Jdcom IncJD | 1 | Buy | $52.00 | N/A | Upgrades | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.